{"url_path":"/sec/pmhs/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1265521/0001493152-26-026615-index.html","accession_number":"0001493152-26-026615","cik":"0001265521","ticker":"PMHS","issuer_name":"Polomar Health Services, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1265521/0001493152-26-026615-index.html","primary_entity_key":"0001265521","primary_entity_name":"Polomar Health Services, Inc."},"word_count":58,"has_tables":true,"body_markdown":"**Item\n5. Other Information**\n\n \n\nDuring\nthe three months ended March 31, 2026, no director or officer, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934,\nas amended, of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”\nas each term is defined in Item 408(a) of Regulation S-K.\n\n \n\n12"}